320 related articles for article (PubMed ID: 32722002)
1. Surface Modification of Iron Oxide-Based Magnetic Nanoparticles for Cerebral Theranostics: Application and Prospection.
Wu Y; Lu Z; Li Y; Yang J; Zhang X
Nanomaterials (Basel); 2020 Jul; 10(8):. PubMed ID: 32722002
[TBL] [Abstract][Full Text] [Related]
2. Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer's Disease.
Luo S; Ma C; Zhu MQ; Ju WN; Yang Y; Wang X
Front Cell Neurosci; 2020; 14():21. PubMed ID: 32184709
[TBL] [Abstract][Full Text] [Related]
3. Metal Nanoparticles in Alzheimer's Disease.
Behera A; Sa N; Pradhan SP; Swain S; Sahu PK
J Alzheimers Dis Rep; 2023; 7(1):791-810. PubMed ID: 37662608
[TBL] [Abstract][Full Text] [Related]
4. Magnetic iron oxide nanoparticles for brain imaging and drug delivery.
Qiao R; Fu C; Forgham H; Javed I; Huang X; Zhu J; Whittaker AK; Davis TP
Adv Drug Deliv Rev; 2023 Jun; 197():114822. PubMed ID: 37086918
[TBL] [Abstract][Full Text] [Related]
5. Size-Controlled Iron Oxide Nanoplatforms with Lipidoid-Stabilized Shells for Efficient Magnetic Resonance Imaging-Trackable Lymph Node Targeting and High-Capacity Biomolecule Display.
Clauson RM; Chen M; Scheetz LM; Berg B; Chertok B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20281-20295. PubMed ID: 29883088
[TBL] [Abstract][Full Text] [Related]
6. Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.
Dadfar SM; Roemhild K; Drude NI; von Stillfried S; Knüchel R; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2019 Jan; 138():302-325. PubMed ID: 30639256
[TBL] [Abstract][Full Text] [Related]
7. Effect of surface modification on magnetization of iron oxide nanoparticle colloids.
Yuan Y; Rende D; Altan CL; Bucak S; Ozisik R; Borca-Tasciuc DA
Langmuir; 2012 Sep; 28(36):13051-9. PubMed ID: 22889238
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
9. A Promising Approach: Magnetic Nanosystems for Alzheimer's Disease Theranostics.
Chaparro CIP; Simões BT; Borges JP; Castanho MARB; Soares PIP; Neves V
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765284
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in iron oxide nanoparticles for brain cancer theranostics: from
Sheervalilou R; Shirvaliloo M; Sargazi S; Ghaznavi H
Expert Opin Drug Deliv; 2021 Jul; 18(7):949-977. PubMed ID: 33567919
[No Abstract] [Full Text] [Related]
11. Application of magnetic iron oxide nanoparticles: Thrombotic activity, imaging and cytocompatibility of silica-coated and carboxymethyl dextrane-coated particles.
Turrina C; Schoenen M; Milani D; Klassen A; Rojas Gonzaléz DM; Cvirn G; Mela P; Berensmeier S; Slabu I; Schwaminger SP
Colloids Surf B Biointerfaces; 2023 Aug; 228():113428. PubMed ID: 37379701
[TBL] [Abstract][Full Text] [Related]
12. Albumin-Functionalized Iron Oxide Nanoparticles for Theranostics: Engineering and Long-Term In Situ Imaging.
Bychkova AV; Yakunina MN; Lopukhova MV; Degtyarev YN; Motyakin MV; Pokrovsky VS; Kovarski AL; Gorobets MG; Retivov VM; Khachatryan DS
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559265
[TBL] [Abstract][Full Text] [Related]
13. Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles-Focus on Alzheimer's and Parkinson's disease.
Hernando S; Santos-Vizcaíno E; Igartua M; Hernandez RM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(5):e1898. PubMed ID: 37157144
[TBL] [Abstract][Full Text] [Related]
14. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
15. Carboxymethyl starch-chitosan-coated iron oxide magnetic nanoparticles for controlled delivery of isoniazid.
Saikia C; Hussain A; Ramteke A; Sharma HK; Maji TK
J Microencapsul; 2015; 32(1):29-39. PubMed ID: 25090597
[TBL] [Abstract][Full Text] [Related]
16. Application of iron oxide nanoparticles in the diagnosis and treatment of leukemia.
Wang Y; Yang Y; Zheng X; Shi J; Zhong L; Duan X; Zhu Y
Front Pharmacol; 2023; 14():1177068. PubMed ID: 37063276
[TBL] [Abstract][Full Text] [Related]
17. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
Farr AC; Xiong MP
Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
[TBL] [Abstract][Full Text] [Related]
18. Multimodal Composite Iron Oxide Nanoparticles for Biomedical Applications.
Pillarisetti S; Uthaman S; Huh KM; Koh YS; Lee S; Park IK
Tissue Eng Regen Med; 2019 Oct; 16(5):451-465. PubMed ID: 31624701
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
